Source: Recursion Pharmaceuticals AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone. Recursion was able to use its artificial intelligence-enabled drug discovery platform to identify an area of biology to target for the treatment of solid tumors and lymphoma, match it with a drug candidate and move … Read more
When a company performs well and I interview its CEO on CNBC, I consider the stock’s performance before fashioning my questions. When a chief executive is hitting it out of the park, the interview is going to be easy. My main objective is to find out if the great numbers are sustainable. Is there something … Read more
Nvidia CEO Jensen Huang delivers a keynote address during the Nvidia GTC Conference at the SAP Center in San Jose, California, on March 18, 2024. Justin Sullivan | Getty Images Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health … Read more
Nvidia CEO Jensen Huang speaks at the Supermicro keynote presentation during the Computex conference in Taipei on June 1, 2023. Walid Berrazeg | Sopa Images | Lightrocket | Getty Images Investors have become so enamored with Nvidia’s artificial intelligence story that they want a piece of anything the chipmaker touches. On Wednesday, Nvidia disclosed in … Read more
Worries over the prospect of elevated interest rates for a longer time horizon linger on investors’ minds, even as stocks reach fresh highs. Nonetheless, analysts remain focused on the bigger picture and are bullish on stocks that offer attractive long-term growth prospects. Investors can weigh the recommendations of Wall Street’s top analysts as they pick … Read more
